Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Open-label, Multi-cohort, Multicenter Study in Patients With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis

NCT06096779 is registered in ClinicalTrials.gov with Genentech, Inc. as lead sponsor.

NCT NCT06096779
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06096779 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Open-label, Multi-cohort, Multicenter Study in Patients With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis
Lead sponsor
Genentech, Inc.
Phase
Phase 2
Overall status
Active, not recruiting
Start date
July 15, 2024
Completion date
December 30, 2027
Enrollment
30 (actual)
Sites
54

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma